Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Lagergren

Showing results (341-350 of 378) with videos related to

Pageof 38
Sort By:
Gastroenterology|February 15, 2021
Mortality, Reoperation, and Hospital Stay Within 90 Days of Primary and Secondary Antireflux Surgery in a Population-Based Multinational StudyManar Yanes, Giola Santoni, John Maret-Ouda, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2020
Antireflux surgery and risk of lung cancer by histological type in a multinational cohort studyManar Yanes, Giola Santoni, John Maret-Ouda, et al.
Journal of Surgical Oncology|December 5, 2013
Factors associated with early recurrence and death after esophagectomy for cancerAndrew R Davies, Andrew Pillai, Pranab Sinha, et al.
Nature Communications|July 17, 2019
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinomaThanos P Mourikis, Lorena Benedetti, Elizabeth Foxall, et al.
Annals of Surgery|December 5, 2019
Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic CountriesJohn Maret-Ouda, Giola Santoni, Karl Wahlin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 22, 2018
Model for Identifying Individuals at Risk for Esophageal AdenocarcinomaAndrew T Kunzmann, Aaron P Thrift, Chris R Cardwell, et al.
Global Epidemiology|November 30, 2022
COVID-19 in people aged 18-64 in Sweden in the first year of the pandemic: Key factors for severe disease and deathAnnika Rosengren, Mia Söderberg, Christina E Lundberg, et al.
European Radiology|March 15, 2023
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinomaJonathan L Moore, Manil Subesinghe, Aida Santaolalla, et al.
Journal of Internal Medicine|May 25, 2022
Severe COVID-19 in people 55 and older during the first year of the pandemic in SwedenAnnika Rosengren, Christina E Lundberg, Mia Söderberg, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 14, 2021
Transition from esophagectomy to endoscopic therapy for early esophageal cancerJason M Dunn, Arasteh Reyhani, Aida Santaolalla, et al.
Pageof 38

Showing results (341-350 of 378) with videos related to

Sort By:
Pageof 38
Gastroenterology|February 15, 2021
Mortality, Reoperation, and Hospital Stay Within 90 Days of Primary and Secondary Antireflux Surgery in a Population-Based Multinational StudyManar Yanes, Giola Santoni, John Maret-Ouda, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2020
Antireflux surgery and risk of lung cancer by histological type in a multinational cohort studyManar Yanes, Giola Santoni, John Maret-Ouda, et al.
Journal of Surgical Oncology|December 5, 2013
Factors associated with early recurrence and death after esophagectomy for cancerAndrew R Davies, Andrew Pillai, Pranab Sinha, et al.
Nature Communications|July 17, 2019
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinomaThanos P Mourikis, Lorena Benedetti, Elizabeth Foxall, et al.
Annals of Surgery|December 5, 2019
Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic CountriesJohn Maret-Ouda, Giola Santoni, Karl Wahlin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 22, 2018
Model for Identifying Individuals at Risk for Esophageal AdenocarcinomaAndrew T Kunzmann, Aaron P Thrift, Chris R Cardwell, et al.
Global Epidemiology|November 30, 2022
COVID-19 in people aged 18-64 in Sweden in the first year of the pandemic: Key factors for severe disease and deathAnnika Rosengren, Mia Söderberg, Christina E Lundberg, et al.
European Radiology|March 15, 2023
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinomaJonathan L Moore, Manil Subesinghe, Aida Santaolalla, et al.
Journal of Internal Medicine|May 25, 2022
Severe COVID-19 in people 55 and older during the first year of the pandemic in SwedenAnnika Rosengren, Christina E Lundberg, Mia Söderberg, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 14, 2021
Transition from esophagectomy to endoscopic therapy for early esophageal cancerJason M Dunn, Arasteh Reyhani, Aida Santaolalla, et al.
Pageof 38